Bromocriptine Treatment of Relapses Seen During Selective Serotonin Re-uptake Inhibitor Treatment of Depression
- 1 August 1995
- journal article
- letter
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 15 (4) , 289-291
- https://doi.org/10.1097/00004714-199508000-00013
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Changes in dopamine metabolism in rat forebrain regions after cessation of long-term fluoxetine treatment: Relationship with brain concentrations of fluoxetine and norfluoxetineLife Sciences, 1994
- Extrapyramidal Symptoms with Selective Serotonin Reuptake InhibitorsThe British Journal of Psychiatry, 1994
- Loss of drug effects during continuation therapyAmerican Journal of Psychiatry, 1993
- Five-Year Outcome for Maintenance Therapies in Recurrent DepressionArchives of General Psychiatry, 1992
- Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regionsBrain Research, 1992
- Three-Year Outcomes for Maintenance Therapies in Recurrent DepressionArchives of General Psychiatry, 1990
- Fluoxetine and Side EffectsArchives of General Psychiatry, 1990
- Recent advances in the treatment of Parkinson's disease: The role of bromocriptineJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
- Neurochemical effects of some ergot derivatives: A basis for their antiparkinson actionsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981